Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Hongtao Lu
Wenjun Guan
Yanhua Zhou
Zhangui Tang
Hong Bao
机构：
[1] Yangtze University,Jingzhou Central Hospital of Cardiology, The Second Clinical Medical College
[2] The First Affiliated Hospital of Yangtze University,Department of Hematology, Jingzhou First People’s Hospital
[3] Central South University,Institute of Cardiovascular Disease, Xiangya Hospital
[4] Jiangling County People’s Hospital of Cardiology,undefined
来源：
Diabetes Therapy | 2019年 / 10卷
关键词：
Antiplatelet agents; Cangrelor; Cardiovascular disease; Clopidogrel; Percutaneous coronary intervention; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 950
页数：13
相关论文
共 50 条
  • [41] Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Hagi, Katsuhiko
    Nitta, Masahiro
    Watada, Hirotaka
    Kaku, Kohei
    Ueki, Kohjiro
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (11) : 1246 - 1261
  • [42] Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Zhang, Qingqing
    Wu, Yucheng
    Fei, Xiaoqiang
    [J]. MEDICINA-LITHUANIA, 2016, 52 (01): : 28 - 34
  • [43] Efficacy and safety of empagliflozin for type 2 diabetes mellitus Meta-analysis of randomized controlled trials
    Zhang, Yun-Jing
    Han, Shi-Liang
    Sun, Xi-Feng
    Wang, Shu-Xiang
    Wang, Hong-Yun
    Liu, Xiao
    Chen, Li
    Xia, Ling
    [J]. MEDICINE, 2018, 97 (43)
  • [44] Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Mao, Song
    Zhang, Aihua
    Huang, Songming
    [J]. ENDOCRINE, 2014, 47 (03) : 758 - 763
  • [45] Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Song Mao
    Aihua Zhang
    Songming Huang
    [J]. Endocrine, 2014, 47 : 758 - 763
  • [46] Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Devi, R.
    Mali, Ghanshyam
    Chakraborty, Indrani
    Unnikrishnan, Mazhuvancherry Kesavan
    Abdulsalim, Suhaj
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (03) : 382 - 392
  • [47] Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Khan, Parvej
    Venkatesh, Shubhashree
    Parveen, Rizwana
    Mishra, Pinki
    Jain, Seema
    Agarwal, Nidhi
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2199 - 2210
  • [48] Acupuncture for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Chen, Chao
    Liu, Jia
    Sun, Mengxiao
    Liu, Weihong
    Han, Juan
    Wang, Hongcai
    [J]. COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2019, 36 : 100 - 112
  • [49] Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Voroneanu, Luminita
    Nistor, Ionut
    Dumea, Raluca
    Apetrii, Mugurel
    Covic, Adrian
    [J]. JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [50] Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? An updated meta-analysis of randomized trials
    Elgendy, Islam Y.
    Huo, Tianyao
    Bhatt, Deepak L.
    Bavry, Anthony A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B88 - B89
12345